Brunswick Exploration Unpacks 302-Metre Lithium Hit as Retail Traders Battle Over ValuationOct 15 Lux Metals Ignites James Bay with 17.57 g/t Gold Intercept Over 19.5 MetresOct 14 Mining Industry Veteran Michael Williams Appointed Executive Chairman of Canadian Uraniumlive
SPONSORED
Health CareCannabisResearch & Development

Study shows medicinal cannabis improves quality of life for seniors

From psychological to physical effects, cannabis use has benefits for the elderly.

•• 3 Min
Study shows medicinal cannabis improves quality of life for seniors

A new study by researchers affiliated with two midwestern universities found that the medicinal use of cannabis improves the quality of life for seniors. A report on the research, "Evaluating the Health-Related Outcomes of Medical Cannabis Use Among the Elderly": Findings from Colorado and Illinois, "was published this week in the journal Clinical Gerontologist. To conduct the study, a team of researchers affiliated with the University of Illinois and the University of Iowa surveyed 139 seniors about their medical cannabis use and self-reported changes in results over a period of one year. The researchers found that medicinal use of cannabis in those over 60 years of age showed a positive association with improvements in health-related quality of life (HRQL) in the subjects. The study showed a "strong positive association" between the frequency of cannabis use by test subjects and self-reported improvements in pain, medical use, and general health-related quality of life. The test subjects did not report a statistically significant association with the use of medicinal cannabis and adverse effects. The study's authors wrote that they found "a strong positive association between a higher frequency of cannabis use and an improvement in HRQL and HCU (health care usage) levels". More pot is better Investigators also found that those participants who used medicinal cannabis most frequently experienced the greatest improvements in their health. "Our regression models also found a strong positive relationship between higher rates of cannabis use and self-reported improvements in pain symptoms," they continued. "The positive relationship between almost daily use and improved reports provides further evidence of the perceived value of medicinal cannabis as a therapeutic approach to pain management." Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws (NORML), said Thursday that many aging Americans are choosing to treat the pain of aging and other medical ailments with cannabis rather than riskier alternatives. A study published last year in the journal JAMA Internal Medicine found that the rate of cannabis use among those over 65 has increased dramatically and steadily since 2006. "These results are hardly surprising," said Armentano in a press release from the group that has been campaigning for cannabis policy reform since 1970. "Many seniors likely have experimented with cannabis firsthand in their youth and are now returning to cannabis as a potential therapy for the relief of many of the health-related symptoms that appear with age, including chronic pain. Many seniors are aware of the litany of serious adverse side effects in connection with available prescription drugs such as opioids, and see medical cannabis as a viable alternative. Clinical Considerations The study's authors noted several clinical implications of their research, including a recommendation that clinicians should acknowledge that "older adults who use cannabis for medicinal purposes experience a range of positive and negative outcomes". They also wrote that clinicians should keep in mind that these results can be experienced together or separately. "While cannabis use appears to improve a number of self-reported outcomes, patients may report underreporting adverse effects and clinicians must be careful to make a direct assessment of the potential risks and harms for older adults who use cannabis for medicinal purposes. included, "they added.

CannabisResearchHealthcare

More from Health Care

Most Popular News

  1. SpaceX’s $8B Spectrum Deal Sends AT&T, Verizon, and T-Mobile Plummeting
  2. Is Project Vault Securing America’s Supply Chain or Squeezing It to the Breaking Point?
  3. Why Gautam Lohia Shifted from Global Consulting to Reboot a $20M Tech Micro-Cap
  4. Everyday Luxury, Unstoppable Scale: Aritzia Delivers 44% Net Revenue Growth
  5. Can Navy SEAL Leadership and Big Tech Scale Revolutionize Airborne Threat Detection?

Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.